| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 751.69K | — |
| Operating expense | — | — |
| Net income | -3.18M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MRKR returned +17.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +1.7% |
| 1 year | +17.4% |
| 5 years | -92.3% |
| 10 years | -97.3% |
| All-time high | $2,982,000.00 (Feb 2003) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MRKR would be worth today ›No. Marker Therapeutics, Inc. has not paid a dividend in the past 12 months.
Marker Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol MRKR.
Marker Therapeutics, Inc. is part of the Healthcare sector.
Marker Therapeutics, Inc. has a market cap of 25.26M USD, based on the latest quote.
